Literature DB >> 15621992

The mutagenic potential of duodenoesophageal reflux.

Jörg Theisen1, Jeffrey H Peters, Martin Fein, Michael Hughes, Jeffrey A Hagen, Steven R Demeester, Tom R Demeester, Peter W Laird.   

Abstract

SUMMARY BACKGROUND DATA: Duodenogastric-esophageal reflux disease is directly linked to Barrett's esophagus and to the development of esophageal adenocarcinoma. Despite this link, little is known about the mutagenic potential of refluxed material on the esophageal mucosa. We hypothesize that the reflux of gastric and duodenal content causes mutations in esophageal mucosa in vivo.
METHODS: Seven Sprague Dawley/Big Blue F1 lacI transgenic rats underwent esophagoduodenostomy (ED) to surgically create duodeno-gastric-esophageal reflux. Fourteen nonoperated rats served as negative (n = 7) and as positive (n = 7/methyl-N-amyl-nitrosamine [MNAN] intraperitoneally) controls. The animals were killed 16 weeks after operation or injection, the entire esophageal mucosa was harvested, and mutation frequency was determined through standard Big Blue Mutagenesis Assay.
RESULTS: Gross esophagitis was evident in all operated animals. The frequency of lacI mutations in esophageal mucosal cells of animals with ED was significantly higher, nearly 1.5-fold, than that of nonoperated animals. Nitrosamine administration resulted in a nearly 20-fold increase of lacI mutation frequency. Thirteen mutations were successfully sequenced, 46% occurred at CpG dinucleotide sites and 61% were either C to T or G to A transitions.
CONCLUSIONS: The data provide preliminary evidence of the mutagenic potential of bile reflux on esophageal epithelium. The specific mutations are markedly higher than would be expected by chance and are similar to that found in p53 mutations of human esophageal adenocarcinoma, providing a link to human esophageal cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15621992      PMCID: PMC1356847          DOI: 10.1097/01.sla.0000150072.55037.e3

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Bile acids: co-mutagenic activity in the Salmonella-mammalian-microsome mutagenicity test: brief communication.

Authors:  S J Silverman; A W Andrews
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

2.  Melphalan-induced mutagenesis in an SV40-based shuttle vector: predominance of A.T----T.A transversions.

Authors:  P Wang; R A Bennett; L F Povirk
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

3.  Alkaline gastroesophageal reflux.

Authors:  C A Pellegrini; T R DeMeester; J A Wernly; L F Johnson; D B Skinner
Journal:  Am J Surg       Date:  1978-02       Impact factor: 2.565

4.  From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

Authors:  P A Jones; J D Buckley; B E Henderson; R K Ross; M C Pike
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

5.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

6.  Bile acids: natural ligands for an orphan nuclear receptor.

Authors:  D J Parks; S G Blanchard; R K Bledsoe; G Chandra; T G Consler; S A Kliewer; J B Stimmel; T M Willson; A M Zavacki; D D Moore; J M Lehmann
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

7.  Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells.

Authors:  M Mazur; B W Glickman
Journal:  Somat Cell Mol Genet       Date:  1988-07

8.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.

Authors:  M C Hollstein; L Peri; A M Mandard; J A Welsh; R Montesano; R A Metcalf; M Bak; C C Harris
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

10.  Role of the components of the gastroduodenal contents in experimental acid esophagitis.

Authors:  K D Lillemoe; L F Johnson; J W Harmon
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

View more
  34 in total

Review 1.  "Mini" gastric bypass: systematic review of a controversial procedure.

Authors:  Kamal K Mahawar; Neil Jennings; James Brown; Ajay Gupta; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.

Authors:  Peng Cheng; Jian-Sheng Li; Jun Gong; Lian-Feng Zhang; Rong-Zhong Chen
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

Review 3.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

4.  The impact of reflux composition on mucosal injury and esophageal function.

Authors:  Daniel S Oh; Jeffrey A Hagen; Martin Fein; Cedric G Bremner; Christy M Dunst; Steven R Demeester; John Lipham; Tom R Demeester
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

Review 5.  Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.

Authors:  Francisco Schlottmann; Daniela Molena; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

6.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

Review 7.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

8.  Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.

Authors:  Jonine D Figueroa; Mary Beth Terry; Marilie D Gammon; Thomas L Vaughan; Harvey A Risch; Fang-Fang Zhang; David E Kleiner; William P Bennett; Christine L Howe; Robert Dubrow; Susan T Mayne; Joseph F Fraumeni; Wong-Ho Chow
Journal:  Cancer Causes Control       Date:  2008-11-07       Impact factor: 2.506

9.  Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus.

Authors:  Peng Cheng; Jian-Sheng Li; Lian-Feng Zhang; Yong-Zhong Chen; Jun Gong
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.